SEC Form 4 · accession 0001179110-16-031183
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey S. Hatfield
Director
Period of report
Nov 1, 2016
Accepted (ET)
Nov 3, 2016 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.25 | Nov 1, 2016 | A | 25,000 | A | — | Nov 1, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option vests in 24 equal installments on each monthly anniversary of the date of grant until fully vested on the 24-month anniversary of the date of grant.